Practo, Healthians, 1mg violate IMC Ethics Code, Delhi HC issues notice

Published On 2022-12-23 11:17 GMT   |   Update On 2022-12-23 11:17 GMT
Advertisement

The Delhi High Court on Tuesday sought the stand of the Centre and the Delhi government on a petition by the Association of Practising Pathologists seeking action against health service aggregators over allegedly misleading advertisements, ridiculous discounts and unsolicited messages.

Justice Prathiba M Singh issued notices on the petition by the association and also made certain online platforms, including Healthians, Tata 1mg and Practo, parties to the proceedings. The court asked these platforms as well as the governments, GST Council and the National Medical Commission to file their response within six weeks.

Advertisement

For more details, check out the link given below:

Practo, Healthians, 1mg Blatantly Violating IMC Ethics Code, Alleges Plea Of 288 Pathologists, Delhi HC Issues Notice


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News